Karolinska Development AB (publ)
Karolinska Development AB (publ) (KDEVF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
kdevf · pe ratio · data through Dec 31, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Karolinska Development AB (publ) (KDEVF) measures how much investors pay for each dollar of the company's trailing earnings. KDEVF's current PE ratio of N/A is calculated by dividing its stock price of $0.26 by its TTM earnings per share of -$0.43.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31
PE Ratio History
2008 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 6 fiscal years · Front-end computedMinQ1 · 25%4.2x
MedianQ3 · 75%130.0x
Max
At N/A, KDEVF's current P/E is lower than in 0% of its annual fiscal year readings over the past 6 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Karolinska Development AB (publ)You KDEVF | $69M | N/A | — | -$0.43 |
 Biostage, Inc. BSTG | $58M | N/A | — | -$0.42 |
 Ecofibre Limited EOFBY | $74M | N/A | — | -$0.12 |
 E-therapeutics Plc ETXPF | $76M | N/A | — | -$0.02 |
 Herantis Pharma Oyj HRPMF | $59M | N/A | — | -$0.24 |
 Kiaro Holdings Corp. KIARF | $0M | N/A | — | -$0.42 |
 Mindset Pharma Inc. MSSTF | $55M | N/A | — | -$0.18 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-12-31Latest FY2023 | 129.97x | $0.02 | — | |
2022-12-31 FY2022 | — | $-0.34 | — | |
2021-12-31 FY2021 | 6.43x | $0.86 | — | |
2020-12-31 FY2020 | — | $-1.05 | — | |
2019-12-31 FY2019 | 1.58x | $3.63 | -87.8% | |
2018-12-31 FY2018 | 12.92x | $0.42 | +569.8% | |
2017-12-31 FY2017 | 1.93x | $2.60 | — | |
2016-12-31 FY2016 | — | $-3.61 | — | |
2015-12-31 FY2015 | — | $-17.57 | — | |
2014-12-31 FY2014 | — | $-6.85 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Karolinska Development AB (publ) (KDEVF) measures how much investors pay for each dollar of the company's trailing earnings. KDEVF's current PE ratio of N/A is calculated by dividing its stock price of $0.26 by its TTM earnings per share of -$0.43.
Frequently asked questions
KDEVF pe ratio · 6 questionsKDEVF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.26 and TTM EPS of -$0.43. Data sourced from Financial Modeling Prep via KDEVF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Karolinska Development AB (publ) SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09